Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2021 16:10 ET | Source: Vaxcyte, Inc.

Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update

FOSTER CITY, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
May 10, 2021 08:30 ET | Source: Vaxcyte, Inc.

Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease

FOSTER CITY, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
May 06, 2021 16:05 ET | Source: Vaxcyte, Inc.

Vaxcyte to Present at BofA Securities 2021 Health Care Conference

FOSTER CITY, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
April 05, 2021 16:30 ET | Source: Vaxcyte, Inc.

Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference

FOSTER CITY, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
March 29, 2021 16:10 ET | Source: Vaxcyte, Inc.

Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

FOSTER CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
March 22, 2021 16:05 ET | Source: Vaxcyte, Inc.

Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021

FOSTER CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
January 06, 2021 08:15 ET | Source: Vaxcyte, Inc.

Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections

FOSTER CITY, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent...
December 22, 2020 08:00 ET | Source: Vaxcyte, Inc.

Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer

FOSTER CITY, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
November 24, 2020 16:05 ET | Source: Vaxcyte, Inc.

Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference

FOSTER CITY, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
November 12, 2020 16:15 ET | Source: Vaxcyte, Inc.

Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update

FOSTER CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right